Abstract:OBJECTIVE:To investigate the levels and influencing factors of phthalate internal exposure in pregnant women (gestation age ≤ 16 weeks).METHODS:During April to June in 2013, 1 020 pregnant women (gestation age ≤ 16 weeks) who had established the maternal care manual were recruited in maternal and child health hospital of Siming District, Xiamen city. Participators were asked to complete a questionnaire to obtain information on socio-demographic characteristics, lifestyle behaviors, and antenatal examination and to provide a urine sample. Finally, 998 pregnant women who provided a urine sample and completed the questionnaire were enrolled. Adopting systematic sampling method, 100 ones were selected randomly among 998 pregnant women. High performance liquid chromatography-electrospray ionization-tandern mass was used to determine the concentration of five phthalate monoesters in each urine, including mono-n-methyl phthalate (MMP), mono-ethyl phthalate (MEP), mono-butyl phthalate (MBP), mono-benzyl phthalate (MBzP), mono-ethylhexyl phthalate (MEHP). Based on the measurements and questionnaire data, multivariate logistic regression was used to analyze the association between the phthalate monoester levels and potential influential factors.RESULTS:The detection rates of MMP, MEP, MBP, MBzP and MEHP in 100 pregnant urine samples were 94%, 93%, 87%, 83%, 99%, respectively. And the urinary median uncorrected concentrations of MMP, MEP, MBP, MBzP and MEHP in 100 urine samples were 20.56, 17.62, 10.15, 2.03, and 5.12 ng/ml, respectively. Specific gravity-corrected concentration were 20.81, 20.36, 12.88, 2.58, 5.00 ng/ml, respectively. The results of multivariate logistic regression analysis indicated that: education degree was negatively associated with urinary concentration of MMP, MEP, MBP, MBzP and MEHP, OR (95% CI) were 0.495 (0.253-0.966), 0.380 (0.191-0.755), 0.379 (0.186-0.774), 0.401 (0.196-0.819), 0.373(0.183-0.762), respectively. Participants who had hair permed and dyed during pregnancy had higher urinary level of MBP and MBzP, OR (95% CI) were 12.867 (1.240-133.525), 15.982 (1.367-186.911), respectively; Participants who use cosmetics during pregnancy had higher urinary level of MEP and MBP, OR (95% CI) were 2.977 (1.012-8.757), 4.440 (1.485-13.272), respectively; plastic bottled water consumption was positively associated with urinary concentrations of MEP and MEHP, OR (95% CI) were 3.780 (1.417-10.083), 2.699 (1.039-7.010), respectively; annual household income was negatively associated with urinary concentration of MMP, OR (95% CI) was 0.597 (0.372-0.959); individuals who took medications during pregnancy had higher urinary level of MEHP than non-takers, OR (95% CI) was 4.853 (1.084-21.732).CONCLUSION:Pregnant women whose gestation age was less than 16 weeks are generally exposed to phthalate. Phthalate internal exposure levels are significantly associated with most measured factors and the influencing factors with different phthalates internal exposure levels are different.

The Associations of Urinary Phthalate Metabolites with the Intermediate and Pregnancy Outcomes of Women Receiving IVF/ICSI Treatments: A Prospective Single-Center Study.

Follicular Fluid and Urinary Concentrations of Phthalate Metabolites among Infertile Women and Associations with in Vitro Fertilization Parameters

Associations Between Phthalate Metabolite Concentrations in Follicular Fluid and Reproductive Outcomes among Women Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment.

Associations Betweenphthalatemetaboliteconcentrationsinfollicularfluidand Reproductive OutcomesamongWomenUndergoing in Vitro Fertilization/ Intracytoplasmic SpermInjectionTreatment

Associations between urinary phthalate concentrations and antral follicle count among women undergoing in vitro fertilization

Predictors of Phthalate Metabolites in Urine and Follicular Fluid and Correlations Between Urine and Follicular Fluid Phthalate Metabolite Concentrations among Women Undergoing in Vitro Fertilization.

Levels of Phthalate Metabolites in Urine of Pregnant Women and Risk of Clinical Pregnancy Loss

Associations between medication use and phthalate metabolites in urine and follicular fluid among women undergoing in vitro fertilization

Associations Between Phthalate Metabolites and Cytokines in the Follicular Fluid of Women Undergoing in Vitro Fertilization.

Associations between exposure to phthalates and liver function among women undergoing assisted reproductive technology

Association of Urinary Bisphenol A Concentrations with in Vitro Fertilisation Outcomes: a Systematic Review and Meta-Analysis Protocol

Follicular Fluid Concentrations of Phthalate Metabolites Are Associated with Altered Intrafollicular Reproductive Hormones in Women Undergoing in Vitro Fertilization

Phthalate Metabolites Related to Infertile Biomarkers and Infertility in Chinese Men.

Maternal urine phthalate metabolite exposure and miscarriage risk: a nested case–control study of the Zunyi Birth Cohort

Urinary Levels of Phthalate Metabolites in Women Associated with Risk of Premature Ovarian Failure and Reproductive Hormones.

Maternal preconception phthalate metabolite concentrations in follicular fluid and neonatal birth weight conceived by women undergoing in vitro fertilization

Monomethyl Phthalate Causes Early Embryo Development Delay, Apoptosis, and Energy Metabolism Disruptions Through Inducing Redox Imbalance

[Levels of Phthalate Internal Exposure Levels in Pregnant Women and Influencing Factors].

Association between phthalate metabolite mixture in neonatal cord serum and birth outcomes

Urinary and seminal plasma concentrations of phthalate metabolites in relation to spermatogenesis-related miRNA106a among men from an infertility clinic

Phthalate metabolites and biomarkers of oxidative stress in the follicular fluid of women undergoing in vitro fertilization